Crossmark

Is the sarcomatous component (homologous vs heterologous) the prognostic “driving force” in early-stage uterine carcinosarcomas? A retrospective multicenter study

Crossref DOI link: https://doi.org/10.1007/s00432-023-04594-5

Published Online: 2023-02-11

Published Print: 2023-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rosati, A.

Vargiu, V.

Certelli, C.

Arcieri, M.

Vizza, E.

Legge, F.

Cosentino, F.

Ferrandina, G.

Fanfani, F.

Scambia, G.

Corrado, G.
Funding

Funding for this research was provided by:

Università Cattolica del Sacro Cuore
License Information

Text and Data Mining valid from 2023-02-11

Version of Record valid from 2023-02-11
More Information

Article History

Received: 7 November 2022

Accepted: 18 January 2023

First Online: 11 February 2023

Declarations

:

: The authors have no relevant financial or non-financial interests to disclose.

Document is current

Any future updates will be listed below